115 results
Page 5 of 6
8-K
EX-99.1
wav59x7
14 Apr 05
FDA Grants Priority Review for Insmed’s NDA for SomatoKine for the Treatment of
12:00am
8-K
EX-99.1
99gk3j djkss451
11 Mar 05
FDA Accepts for Review Insmed’s NDA for SomatoKine® for the Treatment of
12:00am
424B4
31oa4ih1zv rdkcbmvp
6 Aug 03
Prospectus supplement with pricing info
12:00am
8-K
EX-99.1
xz2 t7dotm
11 Jul 03
Financial statements and exhibits
12:00am
10-K405
qpmja4wdh0w 563b3x
25 Mar 02
Annual report (delinquent filer disclosure)
12:00am
10-K
4pocja09
22 Mar 01
Annual report
12:00am
424B4
0uk2gcjrttdnkme6n
27 Oct 00
Prospectus supplement with pricing info
12:00am
S-1/A
k1sxf
24 Oct 00
IPO registration (amended)
12:00am
424A
8wrzc tdyrf
3 Oct 00
Prospectus with significant changes
12:00am
S-1
EX-10.15
42gdwax osah0uels2e
25 Sep 00
IPO registration
12:00am